J J Ferguson
Overview
Explore the profile of J J Ferguson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
106
Citations
800
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Duncan L, Ferguson J, Dunn R, Noling J
J Nematol
. 2009 Mar;
21(4S):707-11.
PMID: 19287677
Taylor's Power Law was fit to Tylenchulus semipenetrans population data obtained from individual trees in a survey of 50 Florida citrus orchards (geographic survey) and to data from individual trees...
2.
Ferguson J, Wilson J, Diez J
Minerva Cardioangiol
. 2007 Oct;
55(5):529-56.
PMID: 17912162
The management of unstable angina/non ST elevation myocardial infarction (UA/NSTEMI) has evolved substantially in recent years. Multiple new antithrombotic options are available; in addition, the use of interventional strategies in...
3.
Kadakia R, Ferguson J
Minerva Cardioangiol
. 2005 Mar;
53(1):15-42.
PMID: 15788977
Recent years have witnessed significant advances in the percutaneous treatment of patients with atherosclerotic vascular disease. Anti-platelet and anti-thrombotic agents are routinely administered to minimize the risk of peri-procedural myonecrosis,...
4.
Serebruany V, Hanley Jr D, Atar D, Ferguson J
Stroke
. 2004 Apr;
35(6):e143.
PMID: 15087566
No abstract available.
5.
Ferguson J
Pharmacoepidemiol Drug Saf
. 2004 Apr;
7(5):339-43.
PMID: 15073981
No abstract available.
6.
Serebruany V, Glassman A, MALININ A, Atar D, Sane D, Oshrine B, et al.
Eur J Heart Fail
. 2003 Aug;
5(4):517-21.
PMID: 12921813
Clinical depression has been identified as an independent risk factor for increased mortality in patients with coronary artery disease. Enhanced platelet activity has been suggested as the mechanism responsible for...
7.
Sekaran N, Moliterno D, Ferguson J, Every N, Anderson H, Aguirre F, et al.
J Thromb Thrombolysis
. 2002 May;
12(3):207-16.
PMID: 11981103
Background And Methods: Because time to presentation to the hospital affects time to treatment and is known to be important in acute myocardial infarction, we evaluated this variable in patients...
8.
9.
Ferguson J, Vaisman D
Expert Opin Investig Drugs
. 2002 Jan;
10(11):1965-76.
PMID: 11772300
The management of acute myocardial infarction (AMI) has changed dramatically over the last two decades, with the addition of fibrinolytic agents and primary coronary intervention (PCI). The more recent development...
10.
Kereiakes D, Grines C, Fry E, Esente P, Hoppensteadt D, Midei M, et al.
J Invasive Cardiol
. 2001 Apr;
13(4):272-8.
PMID: 11287711
Randomized controlled trials of patients with non-ST segment elevation acute coronary syndromes have established the superiority of enoxaparin (versus unfractionated heparin) for reducing adverse ischemic outcomes. Furthermore, adjunctive abciximab therapy...